Our Proven Track Record
Grande Capital acted as the sole sponsor in respect of the IPO of Weili Holdings Limited (stock code: 2372), which was successfully listed on the Main Board of the Stock Exchange of Hong Kong on 30 June 2022. Grande Capital was also appointed as the post-listing compliance adviser to Weili Holdings Limited.
June 2022
_page-0001.jpg/:/cr=t:2.9%25,l:0%25,w:100%25,h:94.21%25/rs=w:388,h:517.3333333333334,cg:true)
Grande Capital acted as the independent financial adviser advising the independent board committee and the independent shareholders of China Logistics Property Holdings Co., Ltd, a company listed on the Main Board of the Stock Exchange of Hong Kong with stock code 1589, in respect of a mandatory general offer made by a subsidiary of JD.com. The deal value was about HK$16.4 billion (approx. US$2.1 billion).
February 2022
_page-0001.jpg/:/cr=t:0%25,l:0%25,w:100%25,h:100%25/rs=w:388,cg:true)
Grande Capital acted as the independent financial adviser advising the independent board committee and the independent shareholders of Chuan Holdings Limited, a company listed on the Main Board of the Stock Exchange of Hong Kong with stock code 1420, in respect of the continuing connected transactions in relation to a supplemental agreement.
January 2022
_page-0001.jpg/:/cr=t:0%25,l:0.02%25,w:99.96%25,h:100%25/rs=w:388,h:517.3333333333334,cg:true)
Grande Capital acted as the financial adviser of Maxicity Holdings Limited in respect of its transfer of listing from GEM to Main Board of the Stock Exchange of Hong Kong.
December 2021
%2020210507_page-0001.jpg/:/cr=t:0%25,l:0.02%25,w:99.96%25,h:100%25/rs=w:388,h:517.3333333333334,cg:true)
Grande Capital acted as the independent financial adviser advising the independent board committee and the independent shareholders of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. , a company listed on the Main Board of the Stock Exchange of Hong Kong with stock code 1349, in respect of its connected transactions in relation to issue and grant of restricted shares.
May 2021
_page-0001.jpg/:/cr=t:0%25,l:0.02%25,w:99.96%25,h:100%25/rs=w:388,h:517.3333333333334,cg:true)
Grande Capital acted as the sole sponsor in respect of the IPO of Unity Enterprise Holdings Limited (stock code: 2195), which is successfully listed on the Main Board of the Stock Exchange of Hong Kong on 31 March 2021. Grande Capital was also appointed as the post-listing compliance adviser to Unity Enterprise Holdings Limited.
March 2021
_page-0001.jpg/:/cr=t:0%25,l:0.02%25,w:99.96%25,h:100%25/rs=w:388,h:517.3333333333334,cg:true)
Grande Capital acted as the independent financial adviser in a connected transaction of China Finance Investment Holdings Limited (a company listed on the Main Board of the Stock Exchange of Hong Kong with stock code 875).
March 2021
_page-0001.jpg/:/cr=t:0%25,l:0.02%25,w:99.96%25,h:100%25/rs=w:388,h:517.3333333333334,cg:true)
Grande Capital acted as the sole sponsor in respect of the IPO of Kwong Luen Engineering Holdings Limited (stock code: 1413), which is successfully listed on the Main Board of the Stock Exchange of Hong Kong on 11 March 2021. Grande Capital was also appointed as the post-listing compliance adviser to Kwong Luen Engineering Holdings Limited.
March 2021
%2020201127_page-0001.jpg/:/cr=t:0%25,l:0.02%25,w:99.96%25,h:100%25/rs=w:388,h:517.3333333333334,cg:true)
Grande Capital acted as the independent financial adviser advising the independent board committee and the independent shareholders of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd., a company listed on the Main Board of the Stock Exchange of Hong Kong with stock code 1349, in respect of the continuing connected transactions in relation to a sales and distribution agreement.
November 2020
_page-0001.jpg/:/cr=t:0%25,l:0.02%25,w:99.96%25,h:100%25/rs=w:388,h:517.3333333333334,cg:true)
Grande Capital acted as the independent financial adviser advising the independent board committee and the independent shareholders of Shenguan Holdings (Group) Limited, a company listed on the Main Board of the Stock Exchange of Hong Kong with stock code is 829, in respect of certain continuing connected transactions.
November 2020
_page-0001.jpg/:/cr=t:0%25,l:0.02%25,w:99.96%25,h:100%25/rs=w:388,h:517.3333333333334,cg:true)
Grande Capital acted as the independent financial adviser advising the independent board committee and the independent shareholders of National Investments Fund Limited (a company listed on the Main Board of the Stock Exchange of Hong Kong whose stock code is 1227) in respect of its proposed rights issue.
November 2020
_page-0001.jpg/:/cr=t:0%25,l:0.02%25,w:99.96%25,h:100%25/rs=w:388,h:517.3333333333334,cg:true)
Grande Capital acted as the independent financial adviser advising the independent board committee and the independent shareholders of China Jicheng Holdings Limited (a company listed on the Main Board of the Stock Exchange of Hong Kong whose stock code is 1027) in respect of its proposed share consolidation.
June 2020
Grande Capital acted as the sole sponsor in respect of the IPO of Wei Yuan Holdings Limited (stock code: 1343), which is successfully listed on the Main Board of the Stock Exchange of Hong Kong on 12 March 2020. Grande Capital was also appointed as the post-listing compliance adviser to Wei Yuan Holdings Limited.
March 2020
Grande Capital acted as the sole sponsor in respect of the IPO of CTR Holdings Limited (stock code: 1416), which is successfully listed on the Main Board of the Stock Exchange of Hong Kong on 15 January 2020. Grande Capital was also appointed as the post-listing compliance adviser to CTR Holdings Limited.
January 2020
Grande Capital acted as the sole sponsor in respect of the IPO of Maxicity Holdings Limited (stock code: 8216), which is successfully listed on the GEM Board of the Stock Exchange of Hong Kong on 13 December 2019. Grande Capital was also appointed as the post-listing compliance adviser to Maxicity Holdings Limited.
December 2019
Grande Capital was appointed as the financial adviser to FSM Holdings Limited (which is a company listed on the Main Board of the Stock Exchange of Hong Kong whose stock code is 1721) in respect of a mandatory unconditional general offer under the Takeovers Code.
December 2019
Grande Capital acted as the independent financial adviser advising the independent board committee and the independent shareholders of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (which is a company listed on the Main Board of the Stock Exchange of Hong Kong whose stock code is 1349) in respect of the continuing connected transactions in relation to a sales and distribution agreement.
October 2019
Grande Capital acted as the sole sponsor in respect of the IPO of S&T Holdings Limited (stock code: 3928), which was successfully listed on the Main Board of the Stock Exchange of Hong Kong on 19 September 2019. Grande Capital was also appointed as the post-listing compliance adviser to S&T Holdings Limited.
September 2019
Grande Capital acted as the sole sponsor in respect of the IPO of Hands Form Holdings Limited (stock code: 1920), which was successfully listed on the Main Board of the Stock Exchange of Hong Kong on 16 August 2019. Grande Capital is also appointed as the post-listing compliance adviser to Hands Form Holdings Limited.
August 2019
Grande Capital acted as the sole sponsor in respect of the IPO of Silver Tide Holdings Limited (stock code: 1943), which was successfully listed on the Main Board of the Stock Exchange of Hong Kong on 28 June 2019. Grande Capital was also appointed as the post-listing compliance adviser to Silver Tide Holdings Limited.
June 2019
Grande Capital acted as the sole sponsor in respect of the IPO of B & D Strategic Holdings Limited (stock code: 1780), which was successfully listed on the Main Board of the Stock Exchange of Hong Kong on 30 April 2019. Grande Capital was also appointed as the post-listing compliance adviser to B & D Strategic Holdings Limited.
April 2019
Grande Capital acted as the sole sponsor in respect of the IPO of Yield Go Holdings Ltd. (stock code: 1796), which was successfully listed on the Main Board of the Stock Exchange of Hong Kong on 31 December 2018. Grande Capital was also appointed as the post-listing compliance adviser to Yield Go Holdings Ltd.
December 2018
Grande Capital was appointed as the financial adviser to Geotech Holdings Ltd. (which is a company listed on the Main Board of the Stock Exchange of Hong Kong whose stock code is 1707) in respect of a mandatory unconditional general offer under the Takeovers Code.
November 2018
Grande Capital acted as the independent financial adviser advising the independent board committee of Mengke Holdings Limited (which is a company listed on the Main Board of the Stock Exchange of Hong Kong whose stock code is 1629) in respect of an unconditional mandatory general offer under the Takeovers Code.
November 2018
Grande Capital acted as the independent financial adviser advising the independent board committee and the independent shareholders of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (which is a company listed on the Main Board of the Stock Exchange of Hong Kong whose stock code is 1349) in respect of the continuing connected transactions in relation to a sales and distribution agreement.
September 2018
FSM Holdings Limited (stock code: 1721) is listed on the Main Board of the Stock Exchange of Hong Kong. Grande Capital acted as the financial adviser to FSM Holdings Limited in respect of its IPO exercise.
June 2018
Grande Capital acted as the financial adviser to South China Financial Holdings Limited (which is a company listed on the Main Board of the Stock Exchange of Hong Kong whose stock code is 619) in respect of a major and connected transaction.
March 2018